help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on March 23, 2006
Molecular Endocrinology, doi:10.1210/me.2005-0409
A more recent version of this article appeared on June 1, 2006
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
20/6/1378    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ward, R. D.
Right arrow Articles by Camper, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ward, R. D.
Right arrow Articles by Camper, S. A.

Submitted on October 12, 2005
Accepted on March 13, 2006

Cell Proliferation and Vascularization in Mouse Models of Pituitary Hormone Deficiency

Robert D. Ward, Brandon M. Stone, Lori T. Raetzman, and Sally A. Camper*

Graduate Program in Cellular and Molecular Biology, Dept. of Human Genetics, University of Michigan, Ann Arbor, MI, USA

* To whom correspondence should be addressed. E-mail: scamper{at}umich.ed.

Mutations in the transcription factors PIT1 and PROP1 lead to pituitary hormone deficiency and hypopituitarism in mice and humans. To determine the basis for this we performed histological analysis of Pit1- and Prop1-deficient dwarf mouse pituitaries throughout fetal and postnatal development. Pit1-deficient mice first exhibit pituitary hypoplasia after birth, primarily caused by reduced cell proliferation, although there is some apoptosis. To determine whether altered development of the vascular system contributes to hypopituitarism, we examined vascularization from e14.5 and throughout development. No obvious differences in vascularization are evident in developing Pit1-deficient pituitaries. In contrast, the Prop1-deficient mouse pituitaries are poorly vascularized and dysmorphic, with a striking elevation in apoptosis. At postnatal day 11, apoptosis-independent caspase-3 activation occurs in thyrotropes and somatotropes of normal but not mutant pituitaries. This suggests that Prop1 and/or Pit1 may be necessary for caspase-3 expression. These studies provide further insight as to the mechanisms of Prop1 and Pit1 action in mice.


Key words: PROP1 • PIT1 • hypopituitarism • caspase • apoptosis




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
L. T. Raetzman, B. S. Wheeler, S. A. Ross, P. Q. Thomas, and S. A. Camper
Persistent Expression of Notch2 Delays Gonadotrope Differentiation
Mol. Endocrinol., November 1, 2006; 20(11): 2898 - 2908.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society